The effect of disease risk probability and disease type on interest in clinic-based versus direct-to-consumer genetic testing services

@article{Sherman2015TheEO,
  title={The effect of disease risk probability and disease type on interest in clinic-based versus direct-to-consumer genetic testing services},
  author={Kerry A Sherman and Laura-Kate E Shaw and Katrina Elizabeth Champion and Fernanda Carolina Cota Caldeira and Margaret McCaskill},
  journal={Journal of Behavioral Medicine},
  year={2015},
  volume={38},
  pages={706-714}
}
The effect of disease-specific cognitions on interest in clinic-based and direct-to-consumer (DTC) genetic testing was assessed. Participants (N = 309) responded to an online hypothetical scenario and received genetic testing-related messages that varied by risk probability (25, 50, 75 %) and disease type (Alzheimer’s disease vs. Type 2 Diabetes). Post-manipulation interest increased for both testing types, but was greater for clinic-based testing. Interest was greater for Type 2 Diabetes than… CONTINUE READING
BETA

Tables and Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 43 REFERENCES

Direct-to-consumer genetic testing: Empowering or endangering the public? [Issue brief

  • G. Javitt
  • Washington: Genetics and PublicPolicyCenter…
  • 2008
Highly Influential
3 Excerpts

Similar Papers

Loading similar papers…